Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_11287 details
Primary information
SALIDSAL_11287
Biomarker nameGlycated hemoglobin A
Biomarker TypeNA
Sampling MethodThis case control study has been done on 44 diabetic (type II) and 44 healthy subjects.
Collection MethodFor collection of unstimulated saliva, from the subjects were asked to spit the saliva into 50 ml laboratory tubes
Analysis MethodSpectrophotometry
Collection SiteSaliva
Disease CategoryMetabolic Disorder
Disease/ConditionType II diabetes
Disease SubtypeNA
Fold Change/ ConcentrationNA
Up/DownregulatedUpregulated
ExosomalNA
OrganismHomo sapiens
PMID31235125
Year of Publication2019
Biomarker IDP69905
Biomarker CategoryProtein
SequenceMVLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR
Title of studyThe effect of glycemic control on salivary lipid peroxidation in type II diabetic patients
Abstract of studyBACKGROUND AND OBJECTIVE: Hyperglycemia and some disturbance in antioxidant system lead to free radicals production and oxidative stress. Assessment of some products of oxidative stress could be effective in evaluation of diabetic control. This study aimed at evaluation of glycemic control on salivary lipid peroxidation in diabetic patients. METHODS: This case control study has been done on 44 diabetic (type II) and 44 healthy subjects. Un-stimulated saliva was collected and correlation between malondialdehid (MDA) as an end -product of lipid peroxidation and HbA1c was assessed. RESULTS: MDA and HbA1c of diabetic patients were significantly higher than control group. There was a indirect correlation between MDA and glycemic control level. CONCLUSION: Evaluation of salivary MDA levels could be useful in prediction of glycemic control.